Resource Center
Welcome to our resource center, your comprehensive hub for valuable information and insights in the field of diagnostic testing and precision medicine. As a leading global provider of specialized laboratory testing services, we understand the importance of staying informed and up-to-date in the ever-evolving world of healthcare diagnostics. The resource center is available to empower healthcare professionals, researchers, and industry stakeholders by offering a wide range of educational materials including; whitepapers, case studies, podcasts, videos, e-books and webinars. Whether you are seeking in-depth knowledge about cutting-edge diagnostic technologies, exploring emerging trends in precision medicine, or looking for practical guidance on test interpretation and patient care, our resources center is your go-to destination for reliable and relevant information. Join us on this journey of discovery and innovation as we strive to enhance patient outcomes and advance the field of diagnostic testing together.
At Eurofins Viracor, our Fighting Fungals brochure highlights our robust fungal testing menu, differential testing capabilities, and commitment to delivering faster results to aid in anti-fungal therapy monitoring. We understand the critical nature of invasive fungal diseases (IFDs), particularly among immunocompromised patients such as organ transplant recipients, HIV/AIDS patients, and those battling cancer. Our advanced diagnostics enable early detection and precise treatment strategies, empowering healthcare providers...
Northwestern Abstract Poster - Association of Under Immunosuppression as Defined by Torque Teno Viral Load and Clinical Outcomes in Kidney Transplant Recipients
Join us for an insightful discussion with Steve Kleiboeker, PhD Vice President, R & D, HCLD/TS/CC (ABB) Chief Scientific Officer, and James Grantham, Senior Scientist, Eurofins Viracor. View the webinar on TTV Viral Load for Monitoring the Net State of Immune Suppression. Don't miss this opportunity to delve into cutting-edge insights.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.